BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 19, 2009
View Archived Issues
Novel B-Raf kinase inhibitors under development at Boehringer Ingelheim for the treatment of cancer
Read More
Novel VEGFR-3 (FLT4) inhibitors prepared and tested at sanofi-aventis
Read More
Sanofi pasteur to assess dengue vaccine in a pediatric clinical study in Thailand
Read More
Phase IIb trial results show longer survival for NSCLC patients treated with TG-4010
Read More
Alkermes initiates phase IIa ALKS-27 study for the treatment of COPD
Read More
GPC Biotech and Agennix plan merger
Read More
Pharmos agrees to sell PRS-639058 and other CB2 agonists to Reperio
Read More
Novel inhibitor of soluble epoxide hydrolase prevents cardiac hypertrophy in rats
Read More
Phase II clinical trial commences for Merck & Co./Arena niacin receptor agonist
Read More
NS-398 inhibits oncogene-regulated hematopoietic differentiation
Read More
Bayer discloses novel GSK-3beta inhibitors for hematological disorders
Read More
Phase III SOFIA study does not achieve primary endpoint in autistic disorder
Read More
Amiloride may prevent cystic fibrosis lung disease
Read More
Protia discloses novel deuterated montelukast analogues with antiasthmatic properties
Read More
Pfizer describes activity of PF-03716556, a novel acid pump antagonist for GERD
Read More
Acyl-AMS inhibitors disrupt Mycobacterium tuberculosis growth in culture
Read More
New ocular hypotensive agents for glaucoma imparted in recent Pfizer patent
Read More
Diamyd receives approval for phase III study of Diamyd in nine European countries
Read More
Bradmer presents update on phase III GLASS-ART clinical trial of Neuradiab in glioblastoma
Read More
FDA accepts Amgen's submission and files denosumab BLA for PMO and bone loss
Read More
FDA sets PDUFA date for review of Zogenix's NDA for migraine drug Sumavel DosePro
Read More
Merck Sharp & Dohme withdraws MAA to EMEA for vorinostat MSD in CTCL
Read More
Plethora Solutions and Sciele Pharma provide clinical update on PSD-502 for premature ejaculation
Read More
FDA reiterates position of complete response regarding Gilead's aztreonam NDA
Read More
FDA extends Hemispherx's NDA review date for Ampligen in CFS
Read More